Penerbitan Terkini

leefern low, farida islahudin, shamin mohd saffian.  (2023).  development of written counseling tool for subcutaneous anticoagulant use in covid-19 patients.  - archives of pharmacy practice.  19-24. 

adyani md redzuan, nur syazwani taridi, farida hanim islahudin, shamin mohd saffian, siti azdiah abdul aziz, mohd makmor bakry, yin mei kuen.  (2023).  assessment of serum digoxin concentration measurement in patients with heart failure and atrial fibrillation.  - malaysian journal of medicine and health sciences.  7. 

lee fern low, farida islahudin, shamin mohd saffian.  (2023).  factors of venous thromboembolism among covid-19 patients.  - asian journal pharmaceutical research health care.  97-104. 

adyani md redzuan, leon ya hui, shamin mohd saffian, farida hanim islahudin, mohd makmor bakry, siti azdiah abdul aziz.  (2023).  features of digoxin toxicity in atrial fibrillation and congestive heart failure patients: a systematic review.  - archives of pharmacy practice.  50-55. 

lee jian lynn, mohamed shah noraida, mohd saffian shamin, makmor-bakry mohd, islahudin farida.  (2023).  population pharmacokinetic modelling of ivig in patients with predominantly antibody deficiencies.  - the japanese journal of therapeutic drug monitoring.  211. 

shamin mohd saffian.  (2023).  unlocking the tips and tricks for a good nights sleep.  - 1twenty80.  28-31. 

kathleen b. olaco, shamin mohd saffian.  (2023).  physicochemical properties and recent modifications of sago (metroxylon sagu) starch for pharmaceutical and food applications: a scoping review.  - malaysian journal of medicine and health sciences.  44-45. 

shamin mohd saffian.  (2023).  1twenty80.  - the d-f ender of health: a pharmacist's sunny side perspective on vitamin d.  26-30. 

mohd saffian, shamin, mohd tahir, nor asyikin, makmor-bakry, mohd, ng, jia wei.  (2023).  safety and effectiveness of dabigatran in patients with atrial fibrillation.  - medicine and health.  14. 

ng, jia wei, mohd tahir, nor asyikin, chin, paul ken leong, makmor-bakry, mohd.  (2023).  the peak and trough concentrations of dabigatran in adult patients.  - medicine and health.  5-6. 

jose de leon, georgios schoretsanitis, robert l. smith, espen molden, anssi solismaa, niko seppala, miloslav kopecek, patrik svancer, ismael olmos, carina ricciardi, celso iglesias-garcia, ana iglesias-alonso, edoardo spina, shamin mohd saffian et al..  (2022).  an international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, crp, and clozapine levels.  - pharmacopsychiatry.  73-86. 

fei yee lee, farida islahudin, abdul halim abdul gafor, hin-seng wong, sunita bavanandan, shamin mohd saffian, adyani md redzuan, mohd makmor-bakry.  (2022).  adverse drug reactions of antihypertensives and cyp3a5*3 polymorphism among chronic kidney disease patients.  - frontiers in pharmacology.  1-8. 

hock peng koh, adyani md redzuan, shamin mohd saffian, jivanraj r. nagarajah, noel thomas ross, hasnita hassan.  (2022).  the outcomes of reperfusion therapy with streptokinase versus tenecteplase in st-elevation myocardial infarction (stemi): a propensity-matched retrospective analysis in an asian population.  - international journal of clinical pharmacy.  641-650. 

farida hanim binti islahudin;mohd bin makmor bakry;adyani binti md redzuan;shamin bin mohd saffian.  (2022).  elucidating mechanism of cyp450 gene polymorphisms on drug metabolism in renal failure.  -

vivisana sothivelr, mohammad y. hasan, shamin m. saffian, satirah zainalabidin, azizah ugusman, mohd k. mahadi.  (2022).  revisiting mirna-21 as therapeutic strategy for myocardial infarction: a systematic review.  - journal of cardiovascular pharmacology.  393-406. 

hock peng koh, adyani md redzuan, shamin mohd saffian, jivanraj r. nagarajah, noel thomas ross, hasnita hassan.  (2022).  clinical profile and predictors of 30-day all-cause mortality of stelevation myocardial infarction (stemi) patients receiving fibrinolytic therapy in an asian population.  - heart & lung.  68-76. 

ahmad salihin abdullah, hwee pheng tan, shamin mohd saffian.  (2022).  bleeding and thromboembolic events in patients with non-valvular atrial fibrillation treated with apixaban or rivaroxaban.  - malaysian journal of medical sciences.  164-172. 

jian lynn lee, shamin mohd saffian, mohd makmor-bakry, farida islahudin, hamidah alias, adli ali, noraida mohamed shah.  (2022).  prescribing practices of intravenous immunoglobulin in tertiary care hospitals in malaysia: a need for a national guideline for immunoglobulin use.  - frontiers in pharmacology.  1-11. 

sareneya dashni rajahthurai, muhammad junaid farrukh, mohd makmor-bakry, hui jan tan, omotayo fatokun, shamin mohd saffian and diana laila ramatillah.  (2022).  use of complementary and alternative medicine and adherence to medication therapy among stroke patients: a meta-analysis and systematic review.  - frontiers in pharmacology.  1-15. 

jia-wei ng, nor asyikin mohd tahir, paul ken leong chin, mohd makmor-bakry, shamin mohd saffian.  (2022).  a systematic review and meta-analysis of dabigatran peak and trough concentration in adults.  - british journal of clinical pharmacology.  4443-4459. 

jose de leon, georgios schoretsanitis, robert l. smith, espen molden, anssi solismaa, niko seppala, miloslav kopecek, patrik svancer, ismael olmos, carina ricciardi, celso iglesias-garcia, ana iglesias-alonso, edoardo spina, shamin mohd saffian et al..  (2022).  correction: an international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, crp, and clozapine levels.  - pharmacopsychiatry.  e1. 

shamin mohd saffian, jian lynn lee, makmor-bakry mohd, farida islahudin, noraida mohamed shah.  (2022).  population pharmacokinetic modeling of intravenous immunoglobulin in patients with immune system disorders.  - cpt: pharmacometrics & systems pharmacology.  S13. 

noraida mohamed shah, jian lynn, lee, shamin mohd saffian, farida islahudin, mohd makmor bakry, hamidah alias.  (2022).  off-labelled uses of intravenous immunoglobulin g at two tertiary hospitals in malaysia.  - 10th asian association of schools of pharmacy (aasp) conference.  1-5. 

hock peng koh, adyani md redzuan, shamin mohd saffian, jivanraj nagarajah, noel thomas ross, hasnita hassan.  (2022).  impact of covid-19 pandemic on stemi thrombolysis and emergency department's performance in a non-pci capable tertiary hospital.  - american journal of emergency medicine.  9-14. 

nor asyikin mohd tahir, baiti kartiqah yahaya, shamin mohd saffian.  (2022).  trends of pharmacogenomic studies in malaysia: a systematic review.  - monash international health science and technology conference (monash inititate 2022).  102. 

shamin mohd saffian, nor aini jamil, nor asyikin mohd tahir, ernieda hatah.  (2022).  vitamin d insufficiency is high in malaysia: a systematic review and meta-analysis of studies on vitamin d status in malaysia.  - frontiers in nutrition.  1-13. 

n.f.s. abdul nasser, n.z. mohd noh, s. mohd saffian, e. noor.  (2022).  the use of concentrated growth factor (cgf) in periodontal osseous surgery and periodontal plastic surgery: a systematic review.  - journal of clinical periodontology.  115. 

ng jia wei, shamin mohd saffian, nor asyikin mohd tahir.  (2021).  safety, efficacy and variability of dabigatran therapy.  - pharmacy research day 2021.  64. 

z. zainal abidin , z.a zainuren, e. noor, n.s mohd nor, s. mohd saffian, r. abdul halim.  (2021).  periodontal health status of children and adolescents with diabetes mellitus: a systematic review and meta-analysis.  - malaysian association of paediatric dentistry (mapd) 2021.  12. 

shamin mohd saffian.  (2021).  vitamin d supplementation should be considered for the treatment of covid-19 infection in malaysia in view of the high prevalence of vitamin d deficiency.  - malaysian journal of medical sciences.  194-196. 

z zainal abidin, za zainuren, e noor, ns mohd nor, s mohd saffian, r abdul halim.  (2021).  periodontal health status of children and adolescents with diabetes mellitus: a systematic review and meta-analysis.  - australian dental journal.  S15-S26. 

fei yee lee, farida islahudin, aina yazrin ali nasiruddin, abdul halim abdul gafor, hin-seng wong, sunita bavanandan, shamin mohd saffian, adyani md redzuan, nurul ain mohd tahir, mohd makmor-bakry.  (2021).  effects of cyp3a5 polymorphism on rapid progression of chronic kidney disease: a prospective, multicentre study.  - journal of personalized medicine.  1-14. 

adyani md redzuan, hock peng koh, shamin mohd saffian, jivanraj r. nagarajah, noel thomas ross, hasnita hassan.  (2021).  the outcomes of streptokinase versus tenecteplase in st-elevation myocardial infarction (stemi): a propensity-matched retrospective analysis in a multiracial asian country.  - 3rd international conference of pharmacy and health sciences 2021 (icphs 2021).  155. 

jian lynn lee, shamin mohd saffian, mohd makmor-bakry, farida islahudin, hamidah alias, lokman mohd noh, intan hakimah ismail, noraida mohamed shah.  (2021).  population pharmacokinetic modelling of intravenous immunoglobulin in patients with predominantly antibody deficiencies.  - british journal of clinical pharmacology.  2956-2966. 

jian lynn lee, noraida mohamed shah, mohd makmor-bakry, farida islahudin, hamidah alias, shamin mohd saffian.  (2021).  a systematic review of population pharmacokinetic analyses of polyclonal immunoglobulin g therapy.  - international immunopharmacology.  1-11. 

noraida mohamed shah, jian lynn lee, shamin mohd saffian, farida h. islahudin, mohd makmor-bakry, hamidah alias, lokman m. noh, intan hakimah ismail.  (2020).  population pharmacokinetics of intravenous immunoglobulin g in patients with primary immunodeficiency in malaysia.  - european society for paediatric infectious diseases (espid 2020).  -. 

jiah ning tan, shamin mohd saffian, fhataheya buang, zakiah jubri, ibrahim jantan, khairana husain, norsyahida mohd fauzi.  (2020).  antioxidant and anti-inflammatory effects of genus gynura: a systematic review.  - frontiers in pharmacology.  1-29. 

nor asyikin mohd tahir, shamin mohd saffian, farida hanim islahudin, abdul halim abdul gafor, mohd makmor-bakry.  (2020).  a meta-analysis on the performance of cystatin c- versus creatinine-based egfr equations in predicting vancomycin clearance.  - journal of korean medical sciences.  1-17. 

jian lynn lee, noraida mohamed shah, mohd makmor-bakry, farida hanim islahudin, hamidah alias, lokman mohd noh, shamin mohd saffian.  (2020).  a systematic review and meta-regression analysis on the impact of increasing igg trough level on infection rates in primary immunodeficiency patients on intravenous igg therapy.  - journal of clinical immunology.  682-698. 

nor asyikin mohd tahir, shamin mohd saffian, farida hanim islahudin, abdul halim abdul gafor, hanita othman, hamizah abdul manan, mohd makmor-bakry.  (2020).  effects of cst3 gene g73a polymorphism on cystatin c in a prospective multiethnic cohort study.  - nephron.  204-212. 

nor asyikin mohd tahir, abdul halim abdul gafor, farida hanim islahudin, shamin mohd saffian, hamizah abdul manan, hanita othman, mohd makmor-bakry.  (2018).  agreement between creatinine and cystatin c-based equations in the estimation of glomerular filtration rate among malaysian patients with renal impairment.  - indian journal of pharmaceutical education and research. 

shamin mohd saffian, stephen brent duffull, daniel frank broughton wright.  (2017).  warfarin dosing algorithms underpredict dose requirements in patients requiring 7 mg daily: a systematic review and meta-analysis.  - clinical pharmacology and therapeutics.  297-304. 

adliah mhd ali, nurul ain mohd tahir, shamin mohd saffian, muhammad faizal ma`arof.  (2017).  cease smoking through technology.  - impact.  9. 

saffian s.m., zhang m., leong chin p.k., jensen b.p..  (2015).  quantification of dabigatran and indirect quantification of dabigatran acylglucuronides in human plasma by lc-ms/ms.  - bioanalysis.  957-966. 

saffian s.m., wright d.f.b., roberts r.l., duffull s.b..  (2015).  methods for predicting warfarin dose requirements.  - therapeutic drug monitoring.  531-538.